Study of MAR001 in Adults With Metabolic Dysfunction

Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight

NCT07110766 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight

NCT06606483 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)

NCT01614782 ·Status: TERMINATED ·Phase: PHASE1

Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD

NCT06564584 ·Status: RECRUITING ·Phase: PHASE2

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

NCT05556512 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)

NCT00092872 ·Status: COMPLETED ·Phase: PHASE3

Phase 1 Study of NGM313 in Healthy Adult Participants

NCT02708576 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults

NCT03100058 ·Status: COMPLETED ·Phase: PHASE2

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

NCT05713799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease

NCT05517564 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)

NCT00533598 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women

NCT07224399 ·Status: RECRUITING ·Phase: PHASE1

Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004)

NCT01088711 ·Status: COMPLETED ·Phase: PHASE1

Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity

NCT06579092 ·Status: COMPLETED ·Phase: PHASE2

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

NCT05822544 ·Status: RECRUITING ·Phase: PHASE1

A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE）

NCT07274137 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of MET233 in Individuals With Obesity or Overweight

NCT07022977 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

NCT06924320 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Phase 1, First Time in Humans Study of NST-1024

NCT04630366 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

NCT05814107 ·Status: COMPLETED ·Phase: PHASE1

A Study of ZT002 Injection in Participants With Overweight or Obesity

NCT06371326 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

NCT01285388 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

NCT01444677 ·Status: COMPLETED ·Phase: PHASE1

First in Human Study in Subjects With Obesity, But Otherwise Healthy

NCT06252220 ·Status: RECRUITING ·Phase: PHASE1

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

NCT02835235 ·Status: COMPLETED ·Phase: PHASE1